Revvity Inc vs Schwab US Large Cap Growth ETF — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while Schwab US Large Cap Growth ETF trades at $34.25. The key difference: Revvity Inc pays a 0.26% dividend while Schwab US Large Cap Growth ETF pays none. Which is the better fit depends on your goals.
| RVTY | SCHG | |
|---|---|---|
Market Cap | $11.87B | — |
Sector | Technology | Sector/Thematic |
52-Week High | $117.75 | $35.30 |
52-Week Low | $82.26 | $28.10 |
Enterprise Value | $14.36B | — |
Dividend Yield | 0.26% | — |
Trailing returns across standard periods
Latest headlines on both assets
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →SCHG is an ETF that seeks to track the total return of the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. The fund provides low-cost exposure to a diversified portfolio of large-capitalization U.S. companies that are classified as growth stocks based on factors such as sales, earnings, and book value growth rates. SCHG is often used by investors seeking long-term capital appreciation from market-leading companies with above-average growth potential.
Read more on SCHG →